‹ All stocks
LTGO
Latigo Biotherapeutics
LTGO · NASDAQ · Healthcare
$15.61
▲ $15.61 (4.07%)
Day range
$14.81 – $15.78
Year range
$14.60 – $25.93
Open
$15.00
Previous close
—
Market cap
$938.99M
Volume (24h)
$72.1K
Volume (52w)
$1.13M
Performance
7D
▼ -1.82%
1M
▼ -31.54%
3M
▼ -14.47%
6M
▼ -14.47%
1Y
▼ -14.47%
YTD
▼ -14.47%
3Y
▼ -14.47%
5Y
▼ -14.47%
All-time
▼ -14.47%
Key statistics
P/E ratio
-24.02
EPS (TTM)
$-0.65
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
60.2M
About Latigo Biotherapeutics
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1179.27 | 0.83% |
JNJ Johnson & Johnson |
$261.44 | 1.93% |
ABBV AbbVie |
$276.47 | 1.49% |
MRK Merck & Co. |
$145.60 | 2.26% |
UNH UnitedHealth Group Incorp… |
$379.30 | 2.25% |
